BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38477374)

  • 1. Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
    Yanagisawa T; Sato S; Hayashida Y; Okada Y; Matsukawa A; Iwatani K; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
    Histopathology; 2024 Jul; 85(1):92-103. PubMed ID: 38477374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer.
    Yanagisawa T; Miki J; Yorozu T; Iwatani K; Obayashi K; Sato S; Kimura T; Takahashi H; Egawa S
    J Urol; 2021 Jun; 205(6):1622-1628. PubMed ID: 33502235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
    Sato S; Yanagisawa T; Miki J; Hayashida Y; Okada Y; Iwatani K; Matsukawa A; Kimura T; Egawa S; Shimoda M; Takahashi H
    Arch Pathol Lab Med; 2024 May; 148(5):573-580. PubMed ID: 37671794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa.
    Yasui M; Ohta JI; Aoki S; Tajirika H; Terao H; Funahashi M; Moriyama M; Hayashi H
    Int Urol Nephrol; 2021 Jun; 53(6):1105-1109. PubMed ID: 33387223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and accuracy of pathological diagnosis in en-bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging by 10 pathologists.
    Yanagisawa T; Yorozu T; Miki J; Iwatani K; Obayashi K; Sato S; Kimura T; Takahashi H; Egawa S
    Histopathology; 2021 Jun; 78(7):943-950. PubMed ID: 33245791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?
    Yanagisawa T; Sato S; Hayashida Y; Okada Y; Iwatani K; Matsukawa A; Kimura T; Takahashi H; Egawa S; Shariat SF; Miki J
    BJU Int; 2023 Feb; 131(2):190-197. PubMed ID: 35488409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
    Yanagisawa T; Matsukawa A; Iwatani K; Sato S; Hayashida Y; Okada Y; Yorozu T; Fukuokaya W; Sakanaka K; Urabe F; Kimura S; Tsuzuki S; Shimoda M; Takahashi H; Miki J; Shariat SF; Kimura T
    Ann Surg Oncol; 2023 Jun; 30(6):3820-3828. PubMed ID: 36897417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
    Grobet-Jeandin E; Wirth GJ; Benamran D; Dupont A; Tille JC; Iselin CE
    Urol Int; 2022; 106(2):130-137. PubMed ID: 33965961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
    Ukai R; Hashimoto K; Nakayama H; Iwamoto T
    Jpn J Clin Oncol; 2017 May; 47(5):447-452. PubMed ID: 28184446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer.
    Eckstein M; Kimmel C; Bruendl J; Weber F; Denzinger S; Gierth M; Burger M; Hartmann A; Otto W; Breyer J
    Sci Rep; 2021 Sep; 11(1):17981. PubMed ID: 34504238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
    Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
    Bertz S; Denzinger S; Otto W; Wieland WF; Stoehr R; Hofstaedter F; Hartmann A
    Histopathology; 2011 Oct; 59(4):722-32. PubMed ID: 22014053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
    Patriarca C; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Guazzoni G; Conti A; Conti G; Lucianò R; Magnani T; Colombo R
    Diagn Pathol; 2016 Jan; 11():6. PubMed ID: 26791567
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Yanagisawa T; Mori K; Motlagh RS; Kawada T; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; D'Andrea D; Compérat E; Miki J; Kimura T; Egawa S; Shariat SF
    J Urol; 2022 Apr; 207(4):754-768. PubMed ID: 35060770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting Progression.
    Budina A; Farahani SJ; Lal P; Nayak A
    Arch Pathol Lab Med; 2022 Sep; 146(9):1131-1139. PubMed ID: 34871364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
    Contieri R; Tan WS; Grajales V; Hensley PJ; Martini A; Bree K; Myers A; Nogueras-Gonzalez G; Navai N; Dinney CP; Guo C; Kamat AM
    BJU Int; 2024 Jun; 133(6):733-741. PubMed ID: 38374533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
    Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
    Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.